ProfileGDS4718 / 242585_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 14% 15% 34% 19% 25% 22% 20% 25% 15% 23% 23% 20% 21% 17% 27% 16% 25% 28% 26% 22% 24% 25% 16% 21% 18% 24% 20% 21% 17% 30% 24% 22% 19% 24% 25% 25% 23% 28% 19% 23% 15% 11% 29% 23% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9535414
GSM549102patient 115, normal, homogenized [OPG study]3.9841415
GSM549104patient 119, normal, homogenized [OPG study]4.6932934
GSM549108patient 138, normal, homogenized [OPG study]4.1460219
GSM549119patient 077, normal, homogenized [OPG study]4.3441625
GSM549133patient 032, cancer, homogenized [OPG study]4.1587422
GSM549139patient 042, cancer, homogenized [OPG study]4.1325420
GSM549099patient 107, normal, homogenized [OPG study]4.3521925
GSM549109patient 139, normal, homogenized [OPG study]3.9791815
GSM549110patient 046, normal, homogenized [OPG study]4.2465223
GSM549114patient 063, normal, homogenized [OPG study]4.2308323
GSM549122patient 082, normal, homogenized [OPG study]4.1681620
GSM549134patient 033, cancer, homogenized [OPG study]4.1900321
GSM549136patient 036, cancer, homogenized [OPG study]3.9709517
GSM549140patient 044, cancer, homogenized [OPG study]4.3746727
GSM549111patient 047, normal, homogenized [OPG study]3.9716216
GSM549113patient 057, normal, homogenized [OPG study]4.3020525
GSM549132patient 031, cancer, homogenized [OPG study]4.4567328
GSM549137patient 038, cancer, homogenized [OPG study]4.3485126
GSM549142patient 047, cancer, homogenized [OPG study]4.3245322
GSM549100patient 110, normal, homogenized [OPG study]4.3144824
GSM549107patient 135, normal, homogenized [OPG study]4.314125
GSM549115patient 068, normal, homogenized [OPG study]3.9472616
GSM549116patient 072, normal, homogenized [OPG study]4.1613221
GSM549120patient 078, normal, homogenized [OPG study]4.0699618
GSM549131patient 030, cancer, homogenized [OPG study]4.2530524
GSM549118patient 074, normal, homogenized [OPG study]4.1410320
GSM549129patient 027, cancer, homogenized [OPG study]4.205121
GSM549123patient 088, normal, homogenized [OPG study]4.0168417
GSM549124patient 006, cancer, homogenized [OPG study]4.5744530
GSM549126patient 015, cancer, homogenized [OPG study]4.2971824
GSM549128patient 025, cancer, homogenized [OPG study]4.2032622
GSM549103patient 117, normal, homogenized [OPG study]4.1490619
GSM549117patient 073, normal, homogenized [OPG study]4.2869224
GSM549138patient 041, cancer, homogenized [OPG study]4.3330325
GSM549141patient 045, cancer, homogenized [OPG study]4.2929225
GSM549130patient 028, cancer, homogenized [OPG study]4.2653923
GSM549101patient 111, normal, homogenized [OPG study]4.4865228
GSM549105patient 128, normal, homogenized [OPG study]4.1172719
GSM549106patient 134, normal, homogenized [OPG study]4.2036323
GSM549112patient 048, normal, homogenized [OPG study]3.9743415
GSM549125patient 011, cancer, homogenized [OPG study]3.8183511
GSM549127patient 024, cancer, homogenized [OPG study]4.4741829
GSM549135patient 035, cancer, homogenized [OPG study]4.2143923